Retatrutide 5/10/20 mg
Retatrutide is a triple agonist of the GIP, GLP-1 and glucagon receptors, studied in metabolic and weight-regulation research.
- Triple GIP / GLP-1 / glucagon receptor agonist
- Subject of metabolic and body-weight research
- Supplied as a lyophilised powder in a sealed vial
For research use only. Not for human consumption.
Retatrutide 5/10/20 mg
Specifications
- Form
- Lyophilised powder
- Strength
- 5/10/20 mg per vial
- Storage
- Store lyophilised vials frozen (-20 °C). After reconstitution, refrigerate at 2–8 °C.
Certificate of Analysis
- Purity (HPLC)
- Published with the current batch COA
- Lot
- Available on request
- Tested by
- Independent third-party lab